ScholarLens Back to search
2019•Biochemical and Biophysical Research CommunicationsRequires access

Mathematical analysis of gefitinib resistance of lung adenocarcinoma caused by MET amplification

Takeshi Ito, Yuki Kumagai, Keiko Itano, Tomoko Maruyama, Kenji Tamura, Shuji Kawasaki, Takashi Suzuki, Yoshinori Murakami

Open publisher page 15 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 15 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Gefitinib, ERBB3, Adenocarcinoma, Epidermal growth factor receptor, Cancer research, Lung cancer, Tyrosine kinase, Drug resistance

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Mathematical analysis of gefitinib resistance of lung adenocarcinoma caused by MET amplification — Research Paper | ScholarLens